Several case-control association studies have raised the possibility that the A allele of a −1438 G/A polymorphism in the type 2A serotonin receptor (HTR2A) gene may be a risk factor for anorexia nervosa. However the absence of linkage and the existence of negative association studies raise the possibility of false positive findings, resulting from population stratification or lack of statistical power. To address this controversy we recruited a sample of 316 patients with anorexia nervosa from six European centres, and utilised a family-based transmission disequilibrium (TDT) approach to analyse the HTR2A-1438 G/A polymorphism. Age at onset and minimal BMI were also taken into consideration in order to detect clinical heterogeneity or a quantitative trait effect. The TDT approach showed that the A allele was transmitted 133 times and not transmitted 148 times (McNemar 2 = 0.29, df = 1, P = 0.59). Also, the haplotypebased haplotype relative risk method showed no evidence for association of the A allele, in samples from each centre ( 2 Ͻ 2.15, df = 1, P Ͼ 0.14) and in the total sample ( 2 = 0.55, df = 1; P = 0.46). Furthermore, we found no evidence for heterogeneity of the A allele frequency between samples ( 2 = 2.54, df = 4, P = 0.64), either according to minimal-BMI (F1/242 = 2.14, P = 0.45) or age at onset (F1/224 = 2.39; P = 0.12). QTL-TDT analyses also showed no direct role of the A allele on these traits. We thus found no evidence for a significant role of the 5-HT 2A gene in anorexia nervosa. Previous results may have been exposed to stratification bias (which we controlled by the TDT method) and/or the risk of type 1 error (from which we were less exposed because of the sample size). Molecular Psychiatry (2002) 7, 90-94.
Introduction
The gene encoding the 5-HT 2A receptor (HTR2A) is a strong candidate for aetiological involvement in anorexia nervosa, 1 because of the role of serotonin in appetite control, sexual behaviour and response to stress, and the interaction between oestrogen and the 5-HT 2A gene. 2 Trait-related abnormalities in the serotonergic system have also been observed in subjects recovered from anorexia nervosa. 3 The A allele of the −1438 G/A polymorphism in HTR2A has been implicated as a vulnerability allele for anorexia nervosa in four case-control association studies. [4] [5] [6] [7] On the other hand, the publication of three negative association studies [8] [9] [10] and current absence of evidence for linkage based on the transmission disequilibrium test (TDT) in 50 family trios 8 raise the possibilities of a false positive finding, a minor effect that is difficult to detect in small samples, and the effect of clinical and/or genetic heterogeneity. The TDT approach has several advantages over case-control studies, for instance the absence of stratification bias and the possibility of showing linkage in the presence of association. 11 This approach nevertheless requires a large sample for substantial statistical power, which is difficult to obtain for infrequent disorders such as anorexia nervosa. A metaor combined analysis of different samples offers an opportunity to increase power, and also allows the potential for detection (and measurement) of heterogeneity between samples.
To obtain a large sample for TDT analysis, six centres from the EC Framework V 'Factors in Healthy Eating' European consortium recruited 316 trios. Three large samples (102 from Centre 1, Paris, France, 90 from Centre 6, Marburg, Germany and 78 from Centre 4, London, UK), a medium-sized one (29 from Centre 2, Milan, Italy) and two small samples (13 from Centre 5, Barcelona, Spain and 4 from Centre 3, Florence, Italy) were combined for analysis. A proportion of the trios (12.7%) described have already been described elsewhere for the 5-HT2A −1438G/A polymorphism and anorexia in published work from Marburg, Germany. 10 Examination of clinical characteristics of the total sample revealed that age at onset was not comparable across the different centres (F5/220 = 2.55, P = 0.029), nor was the minimal adult BMI (F5/238 = 3.99, P = 0.0017). Genetic heterogeneity between centres for this polymorphism was not seen, as 'virtual controls' (ie controls derived from the non-transmitted alleles of the parents to the proband) did not have significantly different distributions across centres ( 2 = 6.66, df = 5, P = 0.57). Hardy-Weinberg equilibrium was found in the total sample of probands for HTR2A genotypes ( 2 = 0.60; df = 1; P = 0.43), as in the sample of 'virtual controls' ( 2 = 0.24; df = 1; P = 0.62). The TDT approach showed that the A allele was transmitted 133 times vs 148 times not transmitted, a difference which was not significantly different from that expected by chance (McNemar 2 = 0.29, df = 1; P = 0.59). Accordingly, the HHRR (table) did not provide evidence for allele-wise association with the −1438 G/A polymorphism, in samples of each centre ( 2 Ͻ 2.15, df = 1, P Ͼ 0.14) and in the total sample ( 2 = 0.55, df = 1; P = 0.46). The genotype distributions were also not significantly different between the total sample of patients with anorexia nervosa and the 'virtual controls' ( 2 = 1.66; df = 2; P = 0.44). The Woolf method did not indicate presence of heterogeneity between centres when the comparison between patients and virtual controls was stratified according to the centre of recruitment. When this heterogeneity is taken into account, the meta-analysis shows no evidence for a role of the AA genotype in anorexia nervosa ( 2 = 0.01, df = 1, P = 0.93). We then performed post hoc analyses, taking into account clinical heterogeneity, and found no difference for patients with the A allele in comparison to patients homozygous for the G allele, considering age at onset and minimum adult BMI. We did not find significant interaction between the A allele and site of recruitment for age at onset (F5/214 = 1.41, P = 0.22) or minimum adult BMI (F5/232 = 1.32; P = 0.26). The QTL-TDT approach was also not in favour of the involvement of HTR2A (−1438G/A polymorphism) in variation of age at onset (F1/223 = 0.02; P Ͼ 0.10) or minimal BMI (F1/239 = 0.45, P Ͼ 0.10) in the sample.
Although our sample size is large, the TDT technique has a lower sensitivity to detect moderate association compared to a case-control sample of similar size. Our negative results may therefore be of limited value if the true odds ratio of the effect of the A allele is small. On the other hand, we estimated the power to detect a significant role of the A allele in anorexia nervosa on the basis of the characteristics of our sample, and found that it is in the range of previous positive associMolecular Psychiatry ation studies for TDT (OR ෂ2), and is larger for the HHRR approach. The family-trio based approach has the advantages of sensitivity, which is close to the casecontrol method when using the HHRR technique and the specificity of non-parametric linkage analysis (in case of association) with TDT. Furthermore, the size of our sample and the clinical investigations performed allowed us a clinical approach that took into consideration potential clinical heterogeneity and allowed the use of quantitative trait information, which has the effect of increasing statistical power.
How is this negative result compatible with the previous positive association findings? Stratification bias is an important potentially confounding factor for casecontrol studies, specifically when the studies are based on heterogeneous populations and allele frequency varies between those populations. These two problems are present in the positive association studies already performed, as the A allele varies between 30% 10 and 42% 8 in control populations, and as the means used to determine geographic and ethnic origins are frequently not detailed. We have good power to detect an association with the HHRR technique (10.4% allele frequency difference being enough in our sample to reach significance) and furthermore we are protected from stratification bias by the within-family association approach. Thus our findings may be a true negative and earlier positive case-control studies false positives. The discrepancy between four positive case-control association studies and the current negative finding could thus be attributed to stratification bias. An alternative explanation is clinical and/or genetic heterogeneity, namely that an unknown subgroup of patients (such as restricting patients) is associated with the A allele, this group being more important in the positive association studies compared to our sample. This hypothesis may be regarded as unsupported, as we firstly did not detect clinical heterogeneity for the A allele between the different sub-samples, and secondly as the first group who showed a positive association 4 also collected patients in this sample, and did not replicate with the TDT and HHRR method what they found with a case-control approach.
If the A allele is involved through linkage disequilibrium with another allele, stratification bias may occur, even in this within-family association study, because of variation of linkage disequilibrium between different samples from various ethnic backgrounds. Nevertheless, explaining the association between the 5-HT 2A gene (−1438 A/G polymorphism) and anorexia nervosa only by linkage disequilibrium between the A allele and another unknown allele is in opposition with the fact that the 5-HT 2A was chosen as a candidate gene (taking into consideration the important role of serotonin in eating disorder in general, and the 5-HT 2A in particular), but cannot be ruled out. Furthermore, the vast majority of this European sample was white European Caucasian in origin, ranging from 92% in France, 99.4% in the UK to 100% in Germany, both Italian centres and Spain. Hence, explaining absence of positive finding because of variation of ethnicity in the dif- ferent subgroups is not likely, although impossible to eliminate. The very similar allele frequency of the A allele in the three large groups of virtual controls (between 40.5% and 42.0%, see Table 1 ) does not favour the hypothesis of population admixture.
In conclusion, this multi-centre analysis does not support a significant role of the 5-HT 2A gene in anorexia nervosa. It comprises the largest set of trios with anorexia nervosa described thus far. Furthermore, the little excess of the A allele in the group of affected patients (compared to 'virtual controls') disappears when heterogeneity between samples is taken into account with the Woolf method.
Methods

Subjects
All patients were assessed with a face-to-face interview screening DSM-IV criteria, with various types of interview according to the country. The French sample was interviewed by a psychiatrist using the Diagnostic Interview for Genetic Studies (DIGS 12 ), the German sample was analysed with the CIDI, 13 the Spanish, Italian (Florence) and British samples were diagnosed using the Structured Clinical Interview for Mental Disorders, research version 2.0, (SCID-I 14 ) , and the Italian (Milan sample) by the Diagnostic Interview ScheduleRevised (DIS-R). 15 All probands met DSM-IV criteria for anorexia nervosa. Clinical information was simplified to three classical characteristics and was available for the majority of the patients. Two hundred and fortyfour of the 316 patients were assessed for lifetime minimal body mass index (BMI), 289 patients for the subtype of anorexia (restricting or binge-eating/purging), and 226 patients for age at onset (based on the year in which the patient had their first symptoms of anorexia, defined as the start of weight loss). As past clinical traits of anorexia nervosa are difficult to recall (such as minimal BMI 16 ), some data were missing. That was the case when the minimum adult BMI could not be accurately recalled, insufficient time had elapsed (Ͻ3 years restricting illness) to make a classification of restricting or binge-eating/purging subtype, or the subject could not provide a clear age at onset.
Female gender was dominant as expected (98.4%), with a total of five males in the sample (1.6%). The majority of anorexic patients could be classified as belonging to the restricting type (n = 192), the other third belonging to the binge eating/purging type (n = 97). The average age at onset of the total sample was 15.8 years old (SD = 3.42), with an average minimal BMI of 13.3 (SD = 1.92).
Statistical analysis
Statistical tests involved calculation of Hardy-Weinberg equilibrium and the haplotype-based haplotype relative risk calculation 17 (HHRR) to allow a combined analysis 18 which may detect heterogeneity between samples, and the transmission disequilibrium test (TDT). The TDT was performed to look for association and linkage between the −1438A putative vulnerability Molecular Psychiatry allele and anorexia nervosa 19 and the related quantitative traits of minimum adult BMI, subtype of diagnosis, and age at onset, using the Q-TDT program. 20 We estimated the statistical power of our sample on the basis of the ␣ risk (5%), the ␤ power (10%) and the A allele frequency (42.7% in 'virtual controls'). It can be computed that 61.95% of trios will be informative. This decreases the HHRR analyses to 196 informative genotypes, or 392 for allele-wise association. The computed threshold for significant difference is 10.4%; an allele frequency of 53.1% in the affected patients will thus lead to significant difference when compared to 42.7% in the virtual control group. With the TDT method, the relative risk of the allele frequency in affected patients is on average 1.80, ranging between 1.46, 7 and 2.36 6 in positive studies. According to Risch and Merikangas, 21 our sample of 316 trios has the power to detect a significant excess of transmission of the vulnerability allele if the relative risk is above 2.03.
DNA analysis
The −1438A/G polymorphism located in the promoter region of the 5-HT 2A gene was analysed on the basis of DNA extracted from blood sample by standard PCR-RFLP analysis procedures, as previously described. 22 
